271 related articles for article (PubMed ID: 32426866)
1. Second cancer risk after primary cancer treatment with three-dimensional conformal, intensity-modulated, or proton beam radiation therapy.
Xiang M; Chang DT; Pollom EL
Cancer; 2020 Aug; 126(15):3560-3568. PubMed ID: 32426866
[TBL] [Abstract][Full Text] [Related]
2. Comparing Risk for Second Primary Cancers After Intensity-Modulated vs 3-Dimensional Conformal Radiation Therapy for Prostate Cancer, 2002-2015.
Pithadia KJ; Advani PG; Citrin DE; Bekelman JE; Withrow DR; Berrington de Gonzalez A; Morton LM; Schonfeld SJ
JAMA Oncol; 2023 Aug; 9(8):1119-1123. PubMed ID: 37289449
[TBL] [Abstract][Full Text] [Related]
3. Intensity-Modulated Radiation Therapy May Improve Local-Regional Tumor Control for Locally Advanced Non-Small Cell Lung Cancer Compared With Three-Dimensional Conformal Radiation Therapy.
Wang J; Zhou Z; Liang J; Feng Q; Xiao Z; Hui Z; Wang X; Lv J; Chen D; Zhang H; Ji Z; Cao J; Liu L; Jiang W; Men Y; Xu C; Dai J; Yin W; Wang L
Oncologist; 2016 Dec; 21(12):1530-1537. PubMed ID: 27628491
[TBL] [Abstract][Full Text] [Related]
4. Comparison of three-dimensional (3D) conformal proton radiotherapy (RT), 3D conformal photon RT, and intensity-modulated RT for retroperitoneal and intra-abdominal sarcomas.
Swanson EL; Indelicato DJ; Louis D; Flampouri S; Li Z; Morris CG; Paryani N; Slopsema R
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1549-57. PubMed ID: 22270176
[TBL] [Abstract][Full Text] [Related]
5. Proton beam radiation therapy results in significantly reduced toxicity compared with intensity-modulated radiation therapy for head and neck tumors that require ipsilateral radiation.
Romesser PB; Cahlon O; Scher E; Zhou Y; Berry SL; Rybkin A; Sine KM; Tang S; Sherman EJ; Wong R; Lee NY
Radiother Oncol; 2016 Feb; 118(2):286-92. PubMed ID: 26867969
[TBL] [Abstract][Full Text] [Related]
6. Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer.
Sheets NC; Goldin GH; Meyer AM; Wu Y; Chang Y; Stürmer T; Holmes JA; Reeve BB; Godley PA; Carpenter WR; Chen RC
JAMA; 2012 Apr; 307(15):1611-20. PubMed ID: 22511689
[TBL] [Abstract][Full Text] [Related]
7. A prospective, comparative analysis of acute toxicity profile between three-dimensional conformal radiotherapy (3DCRT) and intensity-modulated radiotherapy (IMRT) in locally advanced head and neck cancer patients.
Kucha N; Soni TP; Jakhotia N; Patni N; Singh DK; Gupta AK; Sharma LM; Goyal J
Cancer Treat Res Commun; 2020; 25():100223. PubMed ID: 33120316
[TBL] [Abstract][Full Text] [Related]
8. Propensity score-based comparison of survival and radiation pneumonitis after definitive chemoradiation for esophageal cancer: Intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy.
Lan K; Zhu J; Zhang J; Zhou S; Yang Y; Feng Z; Zhang L; Wang S; Xi M
Radiother Oncol; 2020 Aug; 149():228-235. PubMed ID: 32474127
[TBL] [Abstract][Full Text] [Related]
9. Intensity-modulated radiotherapy reduces toxicity with similar biochemical control compared with 3-dimensional conformal radiotherapy for prostate cancer: A randomized clinical trial.
Viani GA; Viana BS; Martin JE; Rossi BT; Zuliani G; Stefano EJ
Cancer; 2016 Jul; 122(13):2004-11. PubMed ID: 27028170
[TBL] [Abstract][Full Text] [Related]
10. Acute toxicity in comprehensive head and neck radiation for nasopharynx and paranasal sinus cancers: cohort comparison of 3D conformal proton therapy and intensity modulated radiation therapy.
McDonald MW; Liu Y; Moore MG; Johnstone PA
Radiat Oncol; 2016 Feb; 11():32. PubMed ID: 26922239
[TBL] [Abstract][Full Text] [Related]
11. Intensity-modulated radiotherapy for the treatment of prostate cancer: a systematic review and economic evaluation.
Hummel S; Simpson EL; Hemingway P; Stevenson MD; Rees A
Health Technol Assess; 2010 Oct; 14(47):1-108, iii-iv. PubMed ID: 21029717
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy-related quality of life in patients with head and neck cancers: a meta-analysis.
Ge X; Liao Z; Yuan J; Mao D; Li Y; Yu E; Wang X; Ding Z
Support Care Cancer; 2020 Jun; 28(6):2701-2712. PubMed ID: 31673782
[TBL] [Abstract][Full Text] [Related]
13. Toxicity and cost-effectiveness analysis of intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy for postoperative treatment of gynecologic cancers.
Chen LA; Kim J; Boucher K; Terakedis B; Williams B; Nickman NA; Gaffney DK
Gynecol Oncol; 2015 Mar; 136(3):521-8. PubMed ID: 25562668
[TBL] [Abstract][Full Text] [Related]
14. Imaging Changes in Pediatric Intracranial Ependymoma Patients Treated With Proton Beam Radiation Therapy Compared to Intensity Modulated Radiation Therapy.
Gunther JR; Sato M; Chintagumpala M; Ketonen L; Jones JY; Allen PK; Paulino AC; Okcu MF; Su JM; Weinberg J; Boehling NS; Khatua S; Adesina A; Dauser R; Whitehead WE; Mahajan A
Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):54-63. PubMed ID: 26279024
[TBL] [Abstract][Full Text] [Related]
15. Comparison of survival, acute toxicities, and dose-volume parameters between intensity-modulated radiotherapy with or without internal target volume delineation method and three-dimensional conformal radiotherapy in cervical cancer patients: A retrospective and propensity score-matched analysis.
Liang YQ; Feng SQ; Xie WJ; Jiang QZ; Yang YF; Luo R; Kidd EA; Zhai TT; Xie LX
Cancer Med; 2022 Jan; 11(1):151-165. PubMed ID: 34821082
[TBL] [Abstract][Full Text] [Related]
16. Acute toxicity with intensity modulated radiotherapy versus 3-dimensional conformal radiotherapy during preoperative chemoradiation for locally advanced rectal cancer.
Ng SY; Colborn KL; Cambridge L; Hajj C; Yang TJ; Wu AJ; Goodman KA
Radiother Oncol; 2016 Nov; 121(2):252-257. PubMed ID: 27751605
[TBL] [Abstract][Full Text] [Related]
17. Intensity-modulated radiation therapy versus three-dimensional conformal radiation therapy with concurrent nedaplatin-based chemotherapy after radical hysterectomy for uterine cervical cancer: comparison of outcomes, complications, and dose-volume histogram parameters.
Isohashi F; Mabuchi S; Yoshioka Y; Seo Y; Suzuki O; Tamari K; Yamashita M; Unno H; Kinose Y; Kozasa K; Sumida I; Otani Y; Kimura T; Ogawa K
Radiat Oncol; 2015 Aug; 10():180. PubMed ID: 26300325
[TBL] [Abstract][Full Text] [Related]
18. Intensity-modulated versus 3-dimensional conformal radiotherapy in the definitive treatment of esophageal cancer: comparison of outcomes and acute toxicity.
Haefner MF; Lang K; Verma V; Koerber SA; Uhlmann L; Debus J; Sterzing F
Radiat Oncol; 2017 Aug; 12(1):131. PubMed ID: 28810885
[TBL] [Abstract][Full Text] [Related]
19. Effect of intensity-modulated pelvic radiotherapy on second cancer risk in the postoperative treatment of endometrial and cervical cancer.
Zwahlen DR; Ruben JD; Jones P; Gagliardi F; Millar JL; Schneider U
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):539-45. PubMed ID: 19427555
[TBL] [Abstract][Full Text] [Related]
20. A comparison of out-of-field dose and its constituent components for intensity-modulated radiation therapy versus conformal radiation therapy: implications for carcinogenesis.
Ruben JD; Lancaster CM; Jones P; Smith RL
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1458-64. PubMed ID: 20950947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
